Dr. Tedros Adhanom Ghebreyesus, the newly appointed WHO Director-General came under fire from NGOs and the public after his appointment of dictatorial Zimbabwean leader Robert Mugabe to the WHO Goodwill Ambassador on October 19th.
This placement was then rescinded by the Director-General on October 22nd due to the mounting pressure against him and the WHO. The 93-year-old leader was removed from his position while Dr. Tedros, repeated that “ the worldwide movement for global health” he aims to build “must work for everyone and include everyone”.
Dr. Tedros, the first African leader of the WHO and the former Ethiopian Foreign Minister and Health Minister, has shown that he is part of the African old guard making an appointment on political lines rather than that of merit-based appointments. This comes to light when his appointment to the WHO was backed by Zimbabwe and the kickback was this Goodwill Ambassador position.
This appointment came as a shock as most of the world knows Mugabe’s 37-year rule of Zimbabwe as fraught with the decimated economy, tyrannical rule, and an all but lifeless healthcare system. So, where does this decision have its roots in some semblance of merit?
Dr. Tedros, when making the announcement of his appointment made reference to Zimbabwe “as a country that places universal health coverage and health promotion at the centre of its policies to provide health care to all”. This is in stark contrast to the reality of the situation. Medicines to treat patients are in short supply added to this it has healthcare workers that go often unpaid. With the system only barely staying afloat with the assistance of international aid. According to the WHO, only one functioning MRI and mammogram machine in operation for the entire country in the public healthcare sector.
This while the WHO Director-General remarks that the leader was the right person to fight to lead the WHO’s fight against NCDs. This from a leader that can be directly linked to the health crisis and the plummeting health of the citizens of his nation.
There is no real indication nor will there most likely be in the reasoning for the appointment in his very short tenure as the Director-General. This monumental blunder in the face of the world has lost Dr. Tedros, the faith and trust he needs to have to carry this important position.
Professor David Wood
President, CEO, The World Heart Federation.
As you may have read, September 13th in New York City, a new global initiative was launched named the Foundation for a Smoke-Free World. This foundation – whose leadership includes former WHO official Dr Derek Yach – is a tobacco industry-funded initiative, set to receive $80 million of annual funding over the next 12 years from Philip Morris International (PMI).
Alongside our colleagues at the WHO Framework Convention on Tobacco Control (FCTC) and the Union, The World Heart Federation condemns this initiative in the strongest possible terms as an attempt by the tobacco industry to interfere in, and subvert public policy.
Despite funding a foundation that claims its goal is to ‘eliminate smoking’, PMI continues to invest billions of dollars in marketing cigarettes worldwide, focusing many of these efforts in low- and middle-income countries to gain new customers.
Throughout previous decades, the tobacco industry – including PMI – has sought to maintain its profits by sowing misinformation among the public and blocking policies designed to protect public health. PMI’s recent failed attempt to sue the government of Uruguay for implementing anti-smoking legislation is just one recent example of these efforts.
Tobacco use remains the leading cause of premature CVD mortality, in some regions accounting for 25-30% of all cardiovascular deaths. According to current WHO projections, tobacco use will kill one billion people this century.
As the leading global advocacy organization bringing together the CVD community to lead heart-healthy lives, the World Heart Federation will continue to support all legitimate efforts to achieve a smoke-free world.
The best path to tackle this epidemic and achieve a smoke-free world is by implementing policies set out in the WHO FCTC – not by engaging with an industry that has shown repeatedly that it cannot be trusted to defend, let alone promote, public health.
We ask you to share information about this foundation with your colleagues and networks so that they can also be made aware of the false nature of this initiative.
3 FEBRUARY 2017 | GENEVA – New guidance from WHO, launched ahead of World Cancer Day (4 February), aims to improve the chances of survival for people living with cancer by ensuring that health services can focus on diagnosing and treating the disease earlier.
New WHO figures released this week indicates that each year 8.8 million people die from cancer, mostly in low- and middle-income countries. One problem is that many cancer cases are diagnosed too late. Even in countries with optimal health systems and services, many cancer cases are diagnosed at an advanced stage, when they are harder to treat successfully.
“Diagnosing cancer in late stages, and the inability to provide treatment, condemns many people to unnecessary suffering and early death,” says Dr Etienne Krug, Director of WHO’s Department for the Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention.
“By taking the steps to implement WHO’s new guidance, healthcare planners can improve early diagnosis of cancer and ensure prompt treatment, especially for breast, cervical, and colorectal cancers. This will result in more people surviving cancer. It will also be less expensive to treat and cure cancer patients.”
All countries can take steps to improve early diagnosis of cancer, according to WHO’s new Guide to cancer early diagnosis.
The three steps to early diagnosis are:
- Improve public awareness of different cancer symptoms and encourage people to seek care when these arise.
- Invest in strengthening and equipping health services and training health workers so they can conduct accurate and timely diagnostics.
- Ensure people living with cancer can access safe and effective treatment, including pain relief, without incurring prohibitive personal or financial hardship.
Challenges are clearly greater in low- and middle-income countries, which have lower abilities to provide access to effective diagnostic services, including imaging, laboratory tests, and pathology – all key to helping detect cancers and plan treatment. Countries also currently have different capacities to refer cancer patients to the appropriate level of care.
WHO encourages these countries to prioritize basic, high-impact and low-cost cancer diagnosis and treatment services. The Organization also recommends reducing the need for people to pay for care out of their own pockets, which prevents many from seeking help in the first place.
Detecting cancer early also greatly reduces cancer’s financial impact: not only is the cost of treatment much less in cancer’s early stages, but people can also continue to work and support their families if they can access effective treatment in time. In 2010, the total annual economic cost of cancer through healthcare expenditure and loss of productivity was estimated at US$ 1.16 trillion.
Strategies to improve early diagnosis can be readily built into health systems at a low cost. In turn, effective early diagnosis can help detect cancer in patients at an earlier stage, enabling treatment that is generally more effective, less complex, and less expensive. For example, studies in high-income countries have shown that treatment for cancer patients who have been diagnosed early are 2 to 4 times less expensive compared to treating people diagnosed with cancer at more advanced stages.
Dr Oleg Chestnov, WHO Assistant Director-General for Noncommunicable Diseases and Mental Health, notes: “Accelerated government action to strengthen cancer early diagnosis is key to meet global health and development goals, including the Sustainable Development Goals (SDGs).”
SDG 3 aims to ensure healthy lives and promote well-being for all at all ages. Countries agreed to a target of reducing premature deaths from cancers and other noncommunicable diseases (NCDs) by one third by 2030. They also agreed to achieve universal health coverage, including financial risk protection, access to quality essential health-care services, and access to safe, effective, quality and affordable essential medicines and vaccines for all. At the same time, efforts to meet other SDG targets, such as improving environmental health and reducing social inequalities can also help reduce the cancer burden.
Cancer is now responsible for almost 1 in 6 deaths globally. More than 14 million people develop cancer every year, and this figure is projected to rise to over 21 million by 2030. Progress on strengthening early cancer diagnosis and providing basic treatment for all can help countries meet national targets tied to the SDGs.
Note to editors:
Most people diagnosed with cancer live in low- and middle-income countries, where two thirds of cancer deaths occur. Less than 30% of low-income countries have generally accessible diagnosis and treatment services, and referral systems for suspected cancer are often unavailable resulting in delayed and fragmented care. The situation for pathology services was even more challenging: in 2015, approximately 35% of low-income countries reported that pathology services were generally available in the public sector, compared to more than 95% of high-income countries.
Comprehensive cancer control consists of prevention, early diagnosis and screening, treatment, palliative care, and survivorship care. All should be part of strong national cancer control plans. WHO has produced comprehensive cancer control guidance to help governments develop and implement such plans to protect people from the onset of cancer and to treat those needing care.
Cancers, along with diabetes, cardiovascular and chronic lung diseases, are also known as NCDs, which were responsible for 40 million (70%) of the world’s 56 million deaths in 2015. More than 40% of the people who died from an NCD were under 70 years of age.
WHO, and the international community, have set targets to reduce such premature NCD deaths by 25% by 2025 and by one third by 2030, the latter as part of the SDGs. Countries have endorsed a range of targets to address NCDs, including making available and affordable basic medical technologies and essential drugs for treating cancers and other conditions in health facilities.
3 FEBRUARY 2017 | GENEVA – New guidance from WHO, launched ahead of World Cancer Day (4 February), aims to improve the chances of survival for people living with cancer by ensuring that health services can focus on diagnosing and treating the disease earlier.
New WHO figures released this week indicates that each year 8.8 million people die from cancer, mostly in low- and middle-income countries. One problem is that many cancer cases are diagnosed too late. Even in countries with optimal health systems and services, many cancer cases are diagnosed at an advanced stage, when they are harder to treat successfully.
“Diagnosing cancer in late stages, and the inability to provide treatment, condemns many people to unnecessary suffering and early death,” says Dr Etienne Krug, Director of WHO’s Department for the Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention.
“By taking the steps to implement WHO’s new guidance, healthcare planners can improve early diagnosis of cancer and ensure prompt treatment, especially for breast, cervical, and colorectal cancers. This will result in more people surviving cancer. It will also be less expensive to treat and cure cancer patients.”
All countries can take steps to improve early diagnosis of cancer, according to WHO’s new Guide to cancer early diagnosis.
The three steps to early diagnosis are:
- Improve public awareness of different cancer symptoms and encourage people to seek care when these arise.
- Invest in strengthening and equipping health services and training health workers so they can conduct accurate and timely diagnostics.
- Ensure people living with cancer can access safe and effective treatment, including pain relief, without incurring prohibitive personal or financial hardship.
Challenges are clearly greater in low- and middle-income countries, which have lower abilities to provide access to effective diagnostic services, including imaging, laboratory tests, and pathology – all key to helping detect cancers and plan treatment. Countries also currently have different capacities to refer cancer patients to the appropriate level of care.
WHO encourages these countries to prioritize basic, high-impact and low-cost cancer diagnosis and treatment services. The Organization also recommends reducing the need for people to pay for care out of their own pockets, which prevents many from seeking help in the first place.
Detecting cancer early also greatly reduces cancer’s financial impact: not only is the cost of treatment much less in cancer’s early stages, but people can also continue to work and support their families if they can access effective treatment in time. In 2010, the total annual economic cost of cancer through healthcare expenditure and loss of productivity was estimated at US$ 1.16 trillion.
Strategies to improve early diagnosis can be readily built into health systems at a low cost. In turn, effective early diagnosis can help detect cancer in patients at an earlier stage, enabling treatment that is generally more effective, less complex, and less expensive. For example, studies in high-income countries have shown that treatment for cancer patients who have been diagnosed early are 2 to 4 times less expensive compared to treating people diagnosed with cancer at more advanced stages.
Dr Oleg Chestnov, WHO Assistant Director-General for Noncommunicable Diseases and Mental Health, notes: “Accelerated government action to strengthen cancer early diagnosis is key to meet global health and development goals, including the Sustainable Development Goals (SDGs).”
SDG 3 aims to ensure healthy lives and promote well-being for all at all ages. Countries agreed to a target of reducing premature deaths from cancers and other noncommunicable diseases (NCDs) by one third by 2030. They also agreed to achieve universal health coverage, including financial risk protection, access to quality essential health-care services, and access to safe, effective, quality and affordable essential medicines and vaccines for all. At the same time, efforts to meet other SDG targets, such as improving environmental health and reducing social inequalities can also help reduce the cancer burden.
Cancer is now responsible for almost 1 in 6 deaths globally. More than 14 million people develop cancer every year, and this figure is projected to rise to over 21 million by 2030. Progress on strengthening early cancer diagnosis and providing basic treatment for all can help countries meet national targets tied to the SDGs.
Note to editors:
Most people diagnosed with cancer live in low- and middle-income countries, where two thirds of cancer deaths occur. Less than 30% of low-income countries have generally accessible diagnosis and treatment services, and referral systems for suspected cancer are often unavailable resulting in delayed and fragmented care. The situation for pathology services was even more challenging: in 2015, approximately 35% of low-income countries reported that pathology services were generally available in the public sector, compared to more than 95% of high-income countries.
Comprehensive cancer control consists of prevention, early diagnosis and screening, treatment, palliative care, and survivorship care. All should be part of strong national cancer control plans. WHO has produced comprehensive cancer control guidance to help governments develop and implement such plans to protect people from the onset of cancer and to treat those needing care.
Cancers, along with diabetes, cardiovascular and chronic lung diseases, are also known as NCDs, which were responsible for 40 million (70%) of the world’s 56 million deaths in 2015. More than 40% of the people who died from an NCD were under 70 years of age.
WHO, and the international community, have set targets to reduce such premature NCD deaths by 25% by 2025 and by one third by 2030, the latter as part of the SDGs. Countries have endorsed a range of targets to address NCDs, including making available and affordable basic medical technologies and essential drugs for treating cancers and other conditions in health facilities.
